Australia Intravenous (IV) Equipments Market Overview, 2031

Australia, like many developed nations, has an aging population. With an increasing number of elderly individuals, there is a higher prevalence of chronic diseases and conditions that may require intravenous therapies. IV equipment is crucial in delivering medications and fluids for the management of these health issues. The prevalence of chronic diseases, such as diabetes, cardiovascular diseases, and cancer, is on the rise in Australia. Many of these conditions often necessitate long-term treatments, including intravenous therapies, driving the demand for IV equipment. With advancements in cancer treatments, there is an increasing use of chemotherapy and other intravenous therapies for cancer patients. The demand for IV equipment in oncology units and infusion centers is consequently on the rise. The experience of global public health emergencies, including the COVID-19 pandemic, has underscored the importance of a well-equipped healthcare system. IV equipment is crucial for various aspects of patient care, including fluid resuscitation and supportive therapies during emergencies. Lifestyle-related health conditions, such as diabetes and cardiovascular diseases, are on the rise globally. IV equipment is frequently used in the management of these conditions, contributing to sustained demand. Australia's healthcare system is increasingly moving toward value-based care models, where the emphasis is on achieving better patient outcomes and experiences. IV equipment that aligns with value-based care principles, including cost-effectiveness and improved patient outcomes, is likely to see increased adoption. Government initiatives promoting the adoption of advanced medical technologies in healthcare facilities can drive the demand for modern IV equipment.


According to the research report, "Australia Intravenous Equipment Market Overview, 2031," published by Bonafide Research, the Australia Intravenous Equipment market was valued at more than 150 Million in 2025.Patient safety remains a top priority in Australia's healthcare system. IV equipment with enhanced safety features, such as dose error reduction systems and alarms to prevent medication errors, is gaining importance. The emphasis on reducing adverse events and enhancing overall patient safety is influencing the design and functionality of IV devices. The expansion of ambulatory care services, including day surgery centers and outpatient clinics, has implications for the use of IV equipment. Compact and portable IV devices that cater to the needs of ambulatory care settings are becoming more relevant. The use of Closed System Transfer Devices is increasing, particularly in the administration of hazardous drugs. These devices help minimize the risk of drug exposure to healthcare workers and patients during the handling and administration of certain medications. The use of peripheral intravenous catheters is on the rise. These catheters are commonly used for short-term IV therapy and are favored for their ease of insertion. On-going improvements in PIVC design and materials contribute to patient comfort and safety. Improvements in alarm systems on infusion pumps and IV equipment aim to alert healthcare providers to potential issues promptly. Advanced alarm features help in preventing and addressing situations such as occlusions, air in the line, or other infusion-related problems. The integration of Radio-Frequency Identification (RFID) technology is a trend in IV equipment. RFID tags on IV bags and equipment enable efficient tracking of medication administration, helping to reduce errors and streamline inventory management.

In Australia’s intravenous (IV) equipment market, a clear pattern emerges where essential fundamentals combine with advanced technologies to meet diverse clinical demands across healthcare settings. IV catheters lead the market in terms of sheer usage and foundational importance because they are indispensable for establishing vascular access the first step in virtually every IV therapy. Peripheral IV catheters, especially single use variants aligned with stringent infection control standards, dominate volume in hospitals, emergency units, and outpatient clinics. These devices form the core of routine infusion interventions, playing a critical role in fluid therapy, drug delivery, and rapid emergency responses. Alongside catheters, IV infusion pumps are a major and fast growing segment, reflecting Australia’s increasing reliance on precision, safety, and technological sophistication in IV delivery. Infusion pumps particularly volumetric, syringe, and ambulatory types are widely used in intensive care units, oncology wards, and surgical suites where controlled and accurate dosing is paramount. Market analysis indicates that advanced infusion technologies continue to expand, driven by demand for smart systems with improved safety features and connectivity that support evidence based practice and reduce medication errors. Other product categories also contribute significantly to Australia’s IV ecosystem that is IV administration sets and solutions remain essential consumables bridging fluids to delivery devices, IV needles and syringes continue to serve routine access and injection needs; and securement devices along with stopcocks and check valves help stabilize catheter placements and manage fluid flow in complex infusion regimens.

In Australia’s IV equipment market, hospitals and clinics including dialysis centers represent the dominant application segment due to their central role in delivering complex medical care and managing high patient throughput. These institutional settings are the primary consumers of IV devices such as catheters, infusion pumps, administration sets, securement systems, and related accessories, which are used daily for surgical procedures, emergency interventions, chronic disease management, and critical care therapies. The robust demand in hospitals arises from both the volume of treatments requiring IV access and the clinical emphasis on patient safety, infection control, and treatment precision. Dialysis centers form a significant sub segment because renal therapy demands repeated and controlled fluid delivery over long durations, reinforcing sustained reliance on reliable IV systems in institutional environments. Ambulatory surgical centers are a growing application area within Australia’s healthcare ecosystem, reflecting broader trends toward outpatient procedures and same day surgeries. In these settings, IV equipment is used primarily for anesthesia administration, perioperative fluid support, and post operative recovery, with portable and easy to use devices favored for efficient patient throughput. ASCs increasingly adopt infusion pumps and simplified IV setups that align with faster treatment cycles and lower resource requirements compared to larger hospital contexts. Home care settings are also gaining prominence, driven by demographic shifts such as an aging population and rising chronic disease prevalence that necessitate long term IV therapies outside traditional care facilities.

Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031



Aspects covered in this report
• Intravenous Equipments Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type
• IV Catheters
• IV Infusion Pumps
• IV Securement Devices
• IV Administration Sets & Solutions
• IV Needles & Syringes
• Stopcocks & Check Valves
• Others

By Application
• Hospitals & Clinics/Dialysis Centers
• Ambulatory Surgical Centers (ASCs)
• Home Care Settings
• Others